DGAP-News: Celesio AG: Celesio is introducing a new pharmacy concept for the European market
(firmenpresse) - DGAP-News: Celesio AG / Key word(s): Miscellaneous
Celesio AG: Celesio is introducing a new pharmacy concept for the
European market
06.12.2012 / 14:00
---------------------------------------------------------------------
Celesio is introducing a new pharmacy concept for the European market
- 'Lloyds' is to become the leading pharmacy brand in Europe
- Pharmacies will be strengthened through innovative service formats,
high-quality products and the latest technology
- Clear commitment to partnership with independent pharmacies
- First pilot pharmacies in the UK and Italy
Stuttgart/London, 6 December 2012. In context with its strategic
realignment, Celesio is concentrating on the further development of its
core business. In the British town of Bicester near London, the company has
introduced today the corner stones of its future European Pharmacy Network
(EPN). These are firstly a new brand strategy for a standardised
pan-European market representation of the Celesio pharmacies, secondly a
new pharmacy concept with innovative service formats, high-quality products
and the latest technology, and thirdly a concept for the cooperation with
independent pharmacies. Together with the Celesio pharmacies, independent
pharmacies will form a pan-European, competitive network, that will support
their independence. In the year 2013 the new concept will be tested in
Europe. Celesio has now opened first pilot pharmacies in the UK and Italy.
The new pharmacy concept is based on comprehensive market studies, best
practices from operating own Celesio pharmacies as well as completely new
developments. After the successful pilot Celesio will step by step convert
its 2,200 own pharmacies in Europe to the new pharmacy concept under the
brand name of 'Lloyds'. Stephan Borchert, member of Celesio's management
board, states: 'Under the name of 'Lloyds', we wish to establish in the
coming years the leading European pharmacy brand. It will stand for
pharmaceutical excellence in service, medical advice and product portfolio
as well as for a new and positive pharmacy experience on the part of the
customers. We will strengthen the pharmacy as a multi-functional
pharmaceutical service and retail concept.'
Pharmacy fittings and design move information, advice and customer care
into the centre. This is achieved especially by establishing a central
'Health Bar' with touch screens for detailed product information, own
consultancy rooms and interactive communication technology.
In a first step, the consultancy service portfolio will mainly focus on the
indications 'skin' and 'pain'. For most pharmacy customers, these fields
are the primary reasons for visiting a pharmacy. Further focus indications
will be added in due course. Competent advice and comprehensive services
will be offered on these indications. For this purpose, Celesio is working
together with independent and renowned organisations in the health market
such as the Skin Health Alliance.
The advice begins with the analysis of skin or pain, respectively. This is
based on state-of-the-art technologies and methods such as digital skin
scanners or interactive pain assessment. A trained medical professional can
be consulted on short notice to confirm the advice provided by the
pharmacist or to transfer the patient to a specialist. In close
collaboration with doctors and independent experts, patients are also
provided detailed information in special events on the topics 'skin' or
'pain'.
Moreover, the pharmacy concept includes methods on compliance management
which have been proven in the Celesio pharmacies on international level and
whose application is subject to the relevant national legislative
framework. Thus the pharmacist supports patients with taking their
medicines in the correct way and on time, preventing negative consequences
to their health as well as follow-up costs that could arise from
non-adherence.
In addition to these service formats for patients, the new pharmacy concept
also entails solutions for efficient pharmacy management such as
intelligent materials management systems. The advantage for the patient:
medications that are in high demand are better available. The advantage for
the pharmacist: stocks and process efforts are reduced and thus costs are
lowered.
The cooperation concept as the third corner stone of the European Pharmacy
Network entails that services are offered to independent partner pharmacies
- either as a complete package or in individual modules. Management board
member Borchert says: 'The cooperation partners alone decide whether and to
what extent they want to use these services. They are therefore determining
the degree of cooperation. With regard to the different national
legislative framework of the health systems, the pharmacy network and its
modules will be tailored to national requirements.'
The planned European Pharmacy Network therefore stands for Celesio's clear
commitment to strengthening the role of pharmacies in the health system and
to partnering with independent pharmacies. Borchert: 'The membership
secures important competitive advantages for independent, owner-managed
pharmacies compared to drugstores and supermarkets in terms of services,
consultancy and performance. They will gain access to innovation and at the
same time to the economic advantages of a large network. This way, the
network will actually serve to guarantee the independence of owner-managed
pharmacies!'
Press contact
Dr Jens Schreiber, Celesio AG, +49 (0)711.5001-380
media(at)celesio.com
Rainer Berghausen, Celesio AG, +49 (0)711.5001-549
media(at)celesio.com
About Celesio Group
As a leading international trading company and provider of logistics and
services in the pharmaceutical and healthcare sector, Celesio takes a
proactive and preventive approach to ensuring that patients receive the
products and support that they require for optimum care. We operate in 17
countries around the world and have about 40,000 employees. Every day, we
serve over 2 million customers - at 2,200 pharmacies of our own and 4,500
participants in our brand partnership schemes. With around 140 wholesale
branches, we supply approximately 65,000 pharmacies and hospitals every day
with up to 130,000 pharmaceutical products. Our services benefit a patient
pool of about 15 million per day.
End of Corporate News
---------------------------------------------------------------------
06.12.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Celesio AG
Neckartalstr. 155
70376 Stuttgart
Germany
Phone: +49 (0)711 5001-735
Fax: +49 (0)711 5001-740
E-mail: investor(at)celesio.com
Internet: www.celesio.comISIN: DE000CLS1001
WKN: CLS100
Indices: MDAX
Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime
Standard), München, Stuttgart; Freiverkehr in Hamburg,
Hannover; Terminbörse EUREX
End of News DGAP News-Service
---------------------------------------------------------------------
196171 06.12.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.12.2012 - 14:00 Uhr
Sprache: Deutsch
News-ID 210320
Anzahl Zeichen: 9056
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 242 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Celesio AG: Celesio is introducing a new pharmacy concept for the European market"
steht unter der journalistisch-redaktionellen Verantwortung von
Celesio AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
